Sibel Health
- Company typePrivate
- Founded2018
- HeadquartersNiles, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Sibel Health firmographics
Firmographics- Name
- Sibel Health
- Legal name
- Sibel Health, Inc.
- Website
- https://sibelhealth.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Sibel Health industry classification
Industry- Product category
- Wireless Wearable Patient Monitoring
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Consumer Health Wearables & Fitness Trackers (Wellness Monitoring) (HLAHACAJ)
- akta.pro secondary industries
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
Keywords
Where Sibel Health is headquartered
LocationHeadquarters
- HQ city
- Niles
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Sibel Health business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Medical device hardware sales: Sales of wireless wearable sensors including the ANNE Chest sensor, ANNE Limb sensor, and ADAM research sensor, along with accessories (ANNE Charger, adhesive patches, ANNE Hub). Devices are clinical-grade, rechargeable, and designed for continuous monitoring.
- Software platform subscriptions (ANNE Care, ANNE View, ANNE Sleep Hub): Recurring revenue from cloud-based monitoring platforms including ANNE Care (remote patient monitoring), ANNE View (bedside application for in-hospital monitoring), and ANNE Sleep Hub (clinical-grade sleep diagnostics). Platforms are HIPAA and GDPR compliant.
- Co-development and licensing revenue: Worldwide collaborative development and commercialization agreement with Maruho Co., Ltd. for a new digital health technology for itch, generating licensing, royalty, and co-development revenue.
- Clinical trial and research data services: Discovery platform offered to pharmaceutical companies (e.g., AbbVie) and academic research institutions for clinical trial data collection, including digital biomarkers for immunology, neurology/CNS, and respiratory indications. Includes end-to-end physiological data collection.
- Non-dilutive research grants: Non-dilutive funding from government agencies and foundations including the Bill & Melinda Gates Foundation ($17.5M for maternal monitoring in LMICs), ARPA-H ($3.5M SBIR Direct-to-Phase II contract for edema monitoring), and FDA ($500,000 Drug Development Tools Research Grant for scratch monitoring).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based enterprise pricing via Request Demo |
Go-to-market motion5 records
Distribution channels5 records
Marketing channels10 records
Sibel Health product offering
Product offeringCore offering
Sibel Health designs, manufactures, and sells FDA-cleared wireless, skin-interfaced wearable biosensors (ANNE Chest, ANNE Limb, ADAM) and cloud-based monitoring platforms (ANNE One, ANNE View, ANNE Care, ANNE Sleep, ANNE Maternal, Discovery) that continuously capture multi-parameter physiological data including ECG, heart rate, respiratory rate, SpO2, temperature, body position, activity, cough, scratch, swallow, vocal biomarkers, and sleep metrics. The offering targets hospitals, health systems, pharmaceutical companies, and clinical research institutions for clinical care, sleep diagnostics, remote patient monitoring, and clinical trials.
Differentiator
Problem solved
Functional benefit
Brands
- ANNE®: Flagship wireless wearable patient monitoring platform and product family from Sibel Health, including ANNE One (continuous multi-parameter monitoring), ANNE Chest (chest sensor), ANNE Limb (SpO2/pulse/temperature sensor), ANNE Care (remote patient monitoring), ANNE View (continuous bedside monitoring app), ANNE Sleep (sleep diagnostics), ANNE Maternal (maternal-fetal monitoring), and the ANNE Hub / ANNE Sleep Hub data platforms.
- ADAM
- Discovery
Products and services
- ANNE One Platform (Clinical Care) FDA-cleared and EU MDR Class IIb CE-marked wireless wearable patient monitoring platform that delivers continuous, multi-parameter monitoring (ECG, heart rate, respiratory rate, SpO2, pulse rate, skin temperature, body position, activity, fall detection) for adult and pediatric inpatient and step-down care. Used by hospitals, health systems, and academic medical centers.
- ANNE Chest Sensor Clinical-grade chest wearable sensor measuring ECG, heart rate, skin temperature, respiratory rate, body position, fall detection, step count, and activity. Uses a 3-axis accelerometer sampling at 416 Hz with up to 7-day battery life, encapsulated in biocompatible medical-grade silicone with a silicone gel adhesive.
- ANNE Limb Sensor Wireless limb-worn wearable sensor measuring SpO2, pulse rate, and skin temperature with 36-hour battery life and biocompatible medical foam adhesive for secure attachment.
- ADAM Sensor Skin-coupled wireless research sensor placed at the suprasternal notch that captures vocal biomarkers, sleep metrics, scratch events, swallow count, body motion, cough count, heart rate, body position, respiratory rate, skin temperature, and step count. Features 3-axis accelerometer and gyroscope with up to 1.6 kHz sampling, 0–45°C temperature sensing, 2.5-day battery life, and hypo-allergenic waterproof silicone housing. Research use only; not FDA cleared and not available in the EU.
- ANNE View Bedside Application FDA-cleared bedside application and central dashboard for multi-patient surveillance that notifies healthcare professionals when physiologic data fall outside clinician-selected thresholds. Used in hospital wards and step-down units.
- ANNE Care Remote Patient Monitoring Platform Cloud-synced remote patient monitoring platform providing real-time health data, personalized insights, and full traceability for at-home patient care. HIPAA- and GDPR-compliant. For research use only.
- ANNE Sleep Diagnostic Platform FDA-cleared hospital-grade sleep diagnostic solution for clinical trials and clinical research. Includes ANNE Sleep Hub and ANNE Sleep Smart Charger (smart charger not FDA-cleared). Not available in the EU.
- Aria Cough Monitoring Sensor Acousto-mechanic sensor for detecting and quantifying cough events in real time while protecting patient privacy. Targeted at clinical trials evaluating treatments for chronic refractory cough affecting up to 7 million adults annually in the U.S.
- Discovery Clinical Trials Platform Comprehensive physiological data collection platform for pharmaceutical, biotech, and academic research customers conducting clinical trials in immunology/inflammation, neurology/CNS, and respiratory indications. Delivers end-to-end digital biomarker capture using the ADAM sensor and Sibel's AI/ML algorithms.
- ANNE Maternal Platform FDA 510(k)-cleared fully wireless maternal-fetal monitoring platform designed for continuous, simultaneous monitoring of maternal and fetal health. Supports labor triage and continuous maternal health monitoring in low- and middle-income countries.
Quantifiable outcome
- Up to 7-day battery life on ANNE Chest sensor with full wireless charge in 5 hours
- +9 more outcomes
Companies that use Sibel Health
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles4 records
Sibel Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature11 records
Sibel Health partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and moderate.
- LookDeep HealthcoreSibel Health and LookDeep Health announced a strategic partnership combining Sibel's continuous, clinical-grade vital signs monitoring with LookDeep's real-time, peer-reviewed vision AI for in-hospital patient monitoring. The integration delivers a more complete view of patient condition across emergency departments, general inpatient units, and hospital-to-home transitions, supporting virtual nursing and earlier intervention without vendor lock-in.
- Ann & Robert H. Lurie Children's Hospital of ChicagocoreStrategic collaboration with Lurie Children's Hospital announced alongside Sibel's 4th FDA clearance for continuous wearable vital signs monitoring with ANNE One, focused on pediatric care and clinical research.
- McGill University and Montreal Children's HospitalmoderateResearch collaboration announced alongside Sibel's FDA clearance for advanced wireless monitoring in neonates and infants at the International Newborn Health Conference.
- Maxim IntegratedmoderateNorthwestern University and Maxim Integrated partnered on next-generation medical sensors, initially focused on wireless devices for COVID-19 monitoring. Sibel Health is spun out of the Querrey Simpson Institute for Bioelectronics at Northwestern, with the partnership supporting the underlying sensor electronics.
- KT Corp.moderateKT Corp., Korea's largest telecommunications company, signed a memorandum of understanding (MoU) with Sibel Health to expand its digital health capabilities, complementing Sibel's Seoul, South Korea office.
- BARDAmoderateThe Biomedical Advanced Research and Development Authority (BARDA) teamed with Northwestern University spinout Sibel Health (then Sonica Health) to develop a clinical-grade wearable to detect signs of COVID-19.
Scale indicators13 records
Recent moves7 records
Expansion highlights7 records
Sibel Health competitors and assessment
Company assessmentDirect peers
- Masimo: Masimo is a global leader in pulse oximetry and continuous patient monitoring, including wearable SET technology for hospital and home settings — directly comparable to Sibel's wireless multi-parameter monitoring of SpO2, ECG, RR, and temperature.
- VitalConnect: VitalConnect offers the FDA-cleared VitalPatch wearable biosensor for continuous multi-parameter vital signs monitoring in hospital and remote settings — a direct competitor to Sibel's ANNE One platform with similar single-use adhesive wearable form factor.
- Empatica: Empatica develops FDA-cleared wearable biosensors (EpiMonitor for epilepsy, Embrace) and digital biomarkers for clinical research — directly comparable to Sibel's mechano-acoustic ADAM and Aria sensors used in clinical trials and digital endpoint development.
- iRhythm Technologies: iRhythm's Zio wearable cardiac monitor provides continuous ambulatory ECG monitoring with AI-based arrhythmia detection — comparable as a wearable, AI-enabled, FDA-cleared diagnostic in clinical care and pharma clinical trial channels.
- BioIntellisense: BioIntellisense's BioSticker and BioButton are FDA-cleared wearable devices for continuous multi-parameter vital sign monitoring — closely comparable to Sibel's ANNE Chest/Limb sensors in form factor and inpatient/RPM use cases.
Broad incumbents
- Philips (Patient Monitoring): Philips is a dominant incumbent in hospital patient monitoring (IntelliVue, wearable biosensor solutions) and remote monitoring — broader portfolio across imaging, sleep, and connected care, but directly competes with ANNE One for inpatient monitoring share.
- GE HealthCare: GE HealthCare's Patient Care Solutions portfolio (e.g., Portrait Mobile wearable sensor) competes directly with Sibel's continuous vital signs monitoring, while its broader hospital and imaging businesses make it a broad incumbent rather than direct peer.
- Medtronic (Patient Monitoring): Medtronic offers continuous monitoring solutions (e.g., Nellcor pulse oximetry, Vital Sync) and large hospital sales infrastructure — overlaps with Sibel on continuous monitoring, though Medtronic's portfolio spans much broader therapeutic and surgical device categories.
Emerging players
- Huxley Medical: Huxley Medical is developing an FDA-cleared wearable cardiorespiratory monitor for sleep and at-home use — an emerging competitor with overlapping focus on continuous wireless monitoring outside the hospital, narrower product line than Sibel.
- Owlet: Owlet makes FDA-cleared wearable infant monitoring (BabySat) and consumer smart sock products — comparable to Sibel's neonatal and maternal programs, but focused primarily on the consumer/pediatric segment rather than hospital inpatient.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Sibel Health social profiles
Digital presenceSibel Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sibel Health leadership team
Management profileNumber of profiles
Profiles6 records
Sibel Health subsidiaries and ownership
Company hierarchySubsidiaries1 record
Sibel Health funding detail
Funding detailFunding overview
Funding rounds9 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sibel Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sibel Health
What does Sibel Health do?
Sibel Health designs, manufactures, and sells FDA-cleared wireless, skin-interfaced wearable biosensors (ANNE Chest, ANNE Limb, ADAM) and cloud-based monitoring platforms (ANNE One, ANNE View, ANNE Care, ANNE Sleep, ANNE Maternal, Discovery) that continuously capture multi-parameter physiological data including ECG, heart rate, respiratory rate, SpO2, temperature, body position, activity, cough, scratch, swallow, vocal biomarkers, and sleep metrics. The offering targets hospitals, health systems, pharmaceutical companies, and clinical research institutions for clinical care, sleep diagnostics, remote patient monitoring, and clinical trials.
Is Sibel Health a public or private company?
Sibel Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Sibel Health founded?
Sibel Health was founded in 2018. It employs 51 to 100 people.
Where is Sibel Health based?
Sibel Health is headquartered in Niles, United States, in the North America region.
How does Sibel Health make money?
Five revenue lines are on record. Medical device hardware sales are the primary driver. The others are software platform subscriptions (ANNE Care, ANNE View, ANNE Sleep Hub), co-development and licensing revenue, clinical trial and research data services and non-dilutive research grants.
Who are Sibel Health's main competitors?
Direct peers on record are Masimo, VitalConnect, Empatica, iRhythm Technologies and BioIntellisense. Broad incumbents are Philips (Patient Monitoring), GE HealthCare and Medtronic (Patient Monitoring). Emerging players are Huxley Medical and Owlet.
Does Sibel Health have an API?
No public API is recorded for Sibel Health.
What industry is Sibel Health in?
Sibel Health's product category is Wireless Wearable Patient Monitoring. Its primary akta.pro industry code is HLAHACAJ, Consumer Health Wearables & Fitness Trackers (Wellness Monitoring), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3841.